Infection prevention
spaces, supporting stringent hygiene protocols and aligning with the National Standards of Healthcare Cleanliness 2025. The sanitising lights enable hospitals and clinics to enhance patient and staff safety while reducing manual cleaning processes. With growing concerns over antimicrobial
resistance, this innovative technology offers a proven, non-invasive, approach to maintaining a healthier clinical environment.
both surface disinfectants and medical device disinfectants, addressing a significant gap in the EU healthcare market. The company’s products meet the latest EN efficacy standards, ensuring fast and effective elimination of a wide range of pathogens including bacterial spores within a short contact time of no longer than 5 minutes. Upcoming innovations include a new formulation in the EU, expanding the company’s portfolio to include a comprehensive range of disinfectants for healthcare settings, ensuring thorough disinfection to protect patient health.
Safer, cleaner, greener gloves ARKA Medical is presenting
R.Advance and
R.Green – higher quality examination gloves designed to offer superior protection for healthcare professionals. The gloves offer: Uncompromising Safety: 100% inspected in a fully automated production line, ensuring the highest standards. Featuring an AQL of 0.65 (
R.Advance) and 1.5 (
R.Green), they are claimed to be up to 50% more resistant (9-10N) than standard gloves. Ultra-Clean Production: Manufactured in a
controlled environment, reducing bioburden by 81% compared to conventional gloves. Innovative Packaging: Designed for single-
glove extraction by the cuff, in line with WHO guidelines. Sustainable & Efficient: Proven to cut glove consumption and waste by approximately 45%, according to trials. Made in Europe,
R.Advance and
R.Green not only enhance infection control but also contribute to a more sustainable and resilient supply chain for European healthcare systems.
more about sepsis and how they can help save lives. The latest module updates (released March 2025) introduce “soft signs”, assisting clinicians to identify sepsis in individuals who communicate differently (such as those with learning disabilities or complex mental health conditions). In anticipation of the future update to the NICE guidelines, new content has been included on improving inclusivity and accuracy of assessment, use of pulse oximetry, and identifying sepsis rashes on darker skin tones.
Hygienic drinking water solutions Borg & Overström are global leaders in hygienic drinking water solutions, committed to providing premium, sustainable, and beautifully designed water dispensers. With over 20 years of innovation, their UK-manufactured systems offer energy-efficient, point-of-use solutions tailored for a variety of environments. The E6 Chilled only dispenser is designed to meet the NHS’s strict water quality standards, ensuring the highest level of hygiene. It features a unique shortened water pathway to eliminate bacteria-harbouring dead legs and uses DryChill rapid cooling for reservoir-free chilling, reducing contamination risks. Borg & Overström’s Totality 5-step purification method guarantees clean, safe drinking water through advanced filtration, antimicrobial sanitisation, and Viovandt UV-C sterilisation. This chemical-free UV technology efficiently eliminates bacteria and viruses, ensuring every glass is fresh and safe. With up to 70% energy savings compared to traditional coolers, the E6 Chilled is a smart, sustainable choice for healthcare and other hygiene-sensitive environments.
Surface and medical device disinfectants Arxada is a global leader in hygiene solutions, dedicated to safeguarding public health and maintaining high hygiene standards. Its innovative formulations and highly effective products are used in various healthcare settings for both low and high-level disinfection. Arxada offers versatile solutions that serve as
32
www.clinicalservicesjournal.com I April 2025
e-Learning modules on sepsis Working as The UK Sepsis Trust’s e-Learning partner, escalla has developed sepsis e-Learning modules to help you understand, identify, and manage sepsis. Aligned with NICE Guidelines NG51 (2024), the modules are targeted at clinicians, care workers, support staff, and the general public; helping everyone to understand
Diagnosing fungal infections Fungal infections are the most underestimated risk of immunocompromised patients. The treatment of an invasive fungal infection is a race against time. Timely detection and treatment are lifesaving. Early diagnosis and optimal antifungal treatment are crucial for favourable outcomes in invasive pulmonary aspergillosis or candidemia. Laboratory tests are mostly batched, meaning
life-saving time can be lost. The test results of individual patients are usually available within days, depending on the number of samples. Furthermore, samples are often referred which can result in additional delay. The TECO FungiLine Fast, from Eurobio
Scientific, was developed to minimise time loss and to enable every hospital laboratory to establish fungal diagnostics. It fulfils essential requirements for the detection of mycological biomarkers via fluorescence based lateral flow cassettes, namely, patient-specific application, fast availability of results, simple combination of relevant biomarkers ((1-3) ß-D-Glucan, galactomannan, galactomannan IgG, candida mannan, mannan IgG, cryptococcal antigen) and efficient analysis with repeated sampling algorithms.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
